Factors Categories | Centralised hospital | Decentralised sites | Total | P-value | |||
No | % | No | % | No | % | ||
| 812 | 52.7 | 730 | 47.3 | 1 542 | 100 |
|
Follow-up time in months | 26.8 (26.6 - 27.0) | ||||||
Baseline weight (SD) | 53.12 (17.0) | ||||||
Age, mean (SD) | 35.7 (10.8) | ||||||
Age at diagnosis | |||||||
18 - 30 | 303 | 19.7 | 245 | 15.9 | 548 | 35.5 | 0.247 |
31 - 40 | 292 | 18.9 | 258 | 16.7 | 550 | 35.7 | |
41 - 50 | 145 | 9.4 | 153 | 9.9 | 298 | 19.3 | |
51 or more | 72 | 4.7 | 74 | 4.8 | 146 | 9.5 | |
Gender | |||||||
Male | 399 | 25.9 | 346 | 22.4 | 745 | 48.3 | 0.264 |
Female | 413 | 26.8 | 384 | 24.9 | 797 | 51.7 | |
Previous MDR-TB episodes | |||||||
No previous MDR-TB episodes | 802 | 52.0 | 673 | 43.6 | 1 475 | 95.7 | <0.001* |
1 previous MDR-TB episode | 9 | 0.6 | 55 | 3.6 | 64 | 4.2 | |
2 or more previous MDR-TB episodes | 1 | 0.1 | 2 | 0.1 | 3 | 0.2 | |
Type of TB | |||||||
Pulmonary TB | 804 | 52.1 | 706 | 45.8 | 1 510 | 97.9 | 0.001* |
Extra-pulmonary TB | 8 | 0.5 | 24 | 1.6 | 32 | 2.1 | |
Comorbidities Conditions | |||||||
No other diseases or conditions | 780 | 92.5 | 9 | 1.1 | 789 | 93.6 | <0.001* |
Diabetes | 10 | 1.2 | 10 | 1.2 | 20 | 2.4 | |
Epilepsy | 4 | 0.5 | 8 | 1.0 | 12 | 1.4 | |
Hearing loss prior to start treatment | 1 | 0.1 | 10 | 1.2 | 11 | 1.3 | |
Renal problems | 0 | 0 | 3 | 0.4 | 3 | 0.4 | |
Substance abuse | 0 | 0 | 4 | 0.5 | 4 | 0.5 | |
Psychiatric problems | 4 | 0.5 | 0 | 0 | 4 | 0.5 | |
HIV status | |||||||
Positive | 576 | 39.1 | 524 | 35.6 | 1 100 | 74.7 | 0.089** |
Negative | 211 | 14.3 | 162 | 11.0 | 373 | 25.3 | |
Status | |||||||
Cured | 439 | 28.5 | 425 | 27.5 | 864 | 56.0 | <0.001* |
Died | 113 | 7.3 | 132 | 8.6 | 245 | 15.9 | |
Defaulted | 229 | 14.9 | 105 | 6.8 | 334 | 21.7 |
|
Lost to follow-up | 31 | 2.0 | 68 | 4.4 | 99 | 6.4 |
|